Temozolomide is a triazene analog of dacarbazine with antineoplastic activity.
As a cytotoxic alkylating agent, temozolomide is converted at physiologic pH to the short-lived active compound, monomethyl triazeno imidazole carboxamide (MTIC).
| Product Name |
Temozolomide |
| CAS Number |
85622-93-1 |
| Therapeutic Class |
Antineoplastic Agents, Alkylating |
| Dosage Form |
Oral Capsule, Powder for injection |
| Availability |
Commercial |
| Regulatory Status |
USDMF, EDMF, CADMF |